Emerging evidence suggests that the HER2/AKT pathway regulates T-ICs in BC by activating the Wnt pathway (Korkaya et al, 2009); however, a precise mechanism of the manner in which Wnt signalling contributes to the BC T-IC phenotype requires further investigation. Here, ERBB2 is linked to breast cancer.